Douglas Rissing
Humacyte (HUMA) added ~27% on Monday after the Durham, North Carolina-based biotech said that the U.S. Congress has passed legislation providing funding to procure human-derived bioengineered vessels such as its lead product, Symvess vascular conduit.
The company noted that the